Shore Capital Partners (“Shore” or “Shore Capital”), a Chicago-based private equity firm with offices in Nashville, announces the formation of PhaseWell Research (“PhaseWell” or the “Company”), a clinical research site company united by a shared commitment to advance the future of medicine. PhaseWell’s network includes industry leaders such as Renstar Medical Research (RMR) and Gabrail Cancer Center Research (GCCR), both known for decades of expertise and consistent delivery of high-quality results across complex therapeutic areas. Backed by a team of more than 70 professionals, over 28 years of clinical research experience, and with a growing footprint nationwide, PhaseWell brings meaningful value to the clinical development process.
Read the full article: Shore Capital Partners Announces Formation of PhaseWell Research and Welcomes Gabrail Cancer Center Research and Renstar Medical Research //
Source: https://www.businesswire.com/news/home/20250813754018/en/Shore-Capital-Partners-Announces-Formation-of-PhaseWell-Research-and-Welcomes-Gabrail-Cancer-Center-Research-and-Renstar-Medical-Research